Related Experiment Videos
Selective serotonin reuptake inhibitor-related extrapyramidal symptoms in autistic children: a case series
Kenneth N Sokolski1, Aleksandra Chicz-Demet, Edward M Demet
1Mental Health Care Group, Veterans Affairs Medical Center, Long Beach, California, USA. Kenneth.Sokolski@med.va.gov
Insights
Selective serotonin reuptake inhibitors (SSRIs) rarely cause abnormal movements. However, four autistic children experienced extrapyramidal side effects (EPS) after SSRI treatment, suggesting a potential complication.
Area of Science:
- Neuroscience
- Pediatric Psychiatry
- Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for various psychiatric conditions.
- While generally well-tolerated, rare adverse effects can occur.
- Autism Spectrum Disorder (ASD) presents unique challenges in medication management.
Observation:
- Four children diagnosed with autism spectrum disorder (ASD) were retrospectively studied.
- These children developed extrapyramidal side effects (EPS) after initiating SSRI therapy.
- Symptoms were assessed using the Extrapyramidal Symptom Rating Scale via clinical notes and parental interviews.
Findings:
- The study identified a potential association between SSRI use and the emergence of EPS in autistic children.
- Extrapyramidal symptoms, though rare with SSRIs, were observed in this specific pediatric population.
- This suggests a possible increased susceptibility in children with ASD.
Implications:
- Clinicians should be vigilant for EPS when prescribing SSRIs to children with autism.
- Further research is warranted to understand the mechanisms and prevalence of SSRI-induced EPS in this population.
- This finding may inform treatment guidelines and risk-benefit assessments for SSRI use in pediatric autism.
Abstract:
Abnormal movements occur rarely with selective serotonin reuptake inhibitors (SSRIs). This report describes four consecutive autistic children who developed extrapyramidal side effects (EPS) following SSRI exposure. Videotapes, physician notes, and parental interviews were used retrospectively to rate symptoms on the Extrapyramidal Symptom Rating Scale. Findings suggest that EPS is a potential complication of SSRI treatment in autistic children.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...